Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Processa Pharma chief business officer Lin buys $4063 in PCSA By Investing.com
Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), purchased 1,603 shares for $4,063 on March 31, 2026. The company is also progressing with its Phase 2 clinical study of NGC-Cap for advanced breast cancer, having completed enrollment and dosing for an interim analysis. InvestingPro analysis indicates that Processa Pharmaceuticals holds more cash than debt and appears undervalued.